Cytokinetics CYTK Net realized gains (losses)
Net realized gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:RealizedInvestmentGainsLosses.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's net realized gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's net realized gains (losses)?
- Cytokinetics (CYTK) reported net realized gains (losses) of $61K in Q1 2026.
- What is the long-term trend for Cytokinetics's net realized gains (losses)?
- Over 2 years (2022 to 2025), Cytokinetics's net realized gains (losses) has grown at a -51.7% compound annual growth rate (CAGR), from -$107K to $25K.
- What does net realized gains (losses) mean?
- Profit or loss realized from selling investment assets.
- How do you interpret net realized gains (losses)?
- Gains indicate successful investment management; losses indicate poor performance or liquidity needs.
- How does net realized gains (losses) compare across companies?
- Common for companies with large cash reserves or investment portfolios.